PLEK2 and breast carcinoma: PLEK2 has been reported to be highly expressed in several tumor types and promotes cancer progression and metastasis, including breast cancer (9), gastric cancer (10), prostate cancer (11), gallbladder cancer (12), and non-small-cell lung cancer (13).